Crohn Disease

Search with Google Search with Bing
Information
Disease name
Crohn Disease
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06082986 Active, not recruiting A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China October 9, 2023 June 21, 2024
NCT05955963 Active, not recruiting N/A Bowel Sounds Analysis in Paediatric Inflammatory Bowel Disease: Relationship With wPCDAI June 24, 2021 June 4, 2024
NCT04520594 Active, not recruiting N/A OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial March 3, 2021 August 1, 2024
NCT05910528 Active, not recruiting Phase 2 RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease July 24, 2023 November 1, 2025
NCT05248191 Active, not recruiting Phase 1 FMT for Postop Crohn's Disease April 20, 2022 December 1, 2025
NCT04245215 Active, not recruiting Phase 3 Loss of RESponse to Ustekinumab Treated by Dose Escalation March 11, 2020 December 2024
NCT04200690 Active, not recruiting N/A Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases January 14, 2020 January 31, 2024
NCT05759104 Active, not recruiting Treatment and Fate in Fistulizing Crohn's Disease in a Pediatric Population January 1, 2012 July 1, 2023
NCT05688852 Active, not recruiting Phase 2 VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease December 22, 2022 May 2027
NCT05221281 Active, not recruiting N/A Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care February 25, 2022 December 31, 2025
NCT04147585 Active, not recruiting N/A Effects of an Intermittent Reduced Calorie Diet on Crohn's Disease December 18, 2019 July 14, 2024
NCT05197049 Active, not recruiting Phase 3 A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease January 19, 2022 March 31, 2025
NCT04088773 Active, not recruiting Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease November 1, 2019 September 2024
NCT04046913 Active, not recruiting N/A The ADDapt Diet in Reducing Crohn's Disease Inflammation September 9, 2019 August 20, 2024
NCT05013905 Active, not recruiting Phase 2 A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease September 1, 2021 January 30, 2026
NCT04013152 Active, not recruiting Clinical Database of Colorectal Robotic Surgery June 13, 2018 June 9, 2027
NCT04978493 Active, not recruiting Phase 2 A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease October 4, 2021 March 1, 2025
NCT02332356 Active, not recruiting Phase 3 Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease September 2014 March 2024
NCT03889613 Active, not recruiting N/A Pillcam Crohn's Capsule for Monitoring of Panenteric Mucosal Healing in Crohn's Disease Patients With Vedolizumab April 3, 2019 November 1, 2024
NCT05177003 Active, not recruiting Study of the 12-month Efficacy of Stem Cell Injection in Crohn's Disease With Complex Ano-perineal Fistula July 2, 2021 December 31, 2024
NCT05611866 Active, not recruiting N/A A Pilot Study of FMT on CD Patients With AIEC October 12, 2022 July 31, 2023
NCT04971525 Active, not recruiting A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With Cancer April 3, 2023 November 13, 2026
NCT04872491 Active, not recruiting A Study of Vedolizumab in Adults in Real-World Practice October 22, 2021 July 5, 2024
NCT04842149 Active, not recruiting N/A The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease May 21, 2021 November 30, 2030
NCT03863704 Active, not recruiting N/A Transcutaneous VNS to Treat Pediatric IBD February 14, 2019 December 31, 2023
NCT03850600 Active, not recruiting N/A Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease January 30, 2019 October 2024
NCT05029921 Active, not recruiting Phase 4 A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease December 10, 2021 August 22, 2025
NCT03798691 Active, not recruiting Phase 4 Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab May 28, 2019 September 2024
NCT04798625 Active, not recruiting Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication February 15, 2021 February 15, 2027
NCT05594862 Active, not recruiting N/A Treatment of Crohn's Complex Perianal Fistulas With Tissue Transplantation by Local Injection of Micro-fragmented Autologous Adipose Tissue. January 9, 2023 December 31, 2024
NCT01765439 Active, not recruiting N/A The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease February 2014 March 2025
NCT06036680 Active, not recruiting Long-term Study of Endoscopic Treatment of Stenosis in Crohn´s Disease December 19, 2022 December 31, 2023
NCT05572203 Active, not recruiting N/A Phenotyping of Adult Crohn's Focusing on Sarcopenia April 14, 2022 December 1, 2023
NCT04673357 Active, not recruiting Phase 3 A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease April 6, 2021 July 25, 2025
NCT03773237 Active, not recruiting N/A Intralipid Versus SMOFlipid in HPN Patients December 31, 2018 September 2024
NCT03706664 Active, not recruiting N/A Small Bowel Deep Learning Algorithm Project March 1, 2019 December 2025
NCT06113913 Active, not recruiting Phase 4 Subcutaneous Infliximab After A Previous Intravenous Dose Optimization April 9, 2024 November 2026
NCT03492944 Active, not recruiting Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason March 6, 2020 January 2025
NCT03481751 Active, not recruiting Validation and Interobserver Reliability of a Simple Ultrasound Score for Crohn's Disease January 8, 2018 December 20, 2022
NCT03462875 Active, not recruiting The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota August 29, 2018 February 28, 2024
NCT03440372 Active, not recruiting Phase 3 Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease February 27, 2018 March 24, 2025
NCT04565821 Active, not recruiting N/A Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe November 12, 2020 April 30, 2027
NCT03340519 Active, not recruiting Early MRI Prediction of Crohns December 17, 2018 September 25, 2024
NCT04522271 Active, not recruiting N/A Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) August 25, 2020 May 1, 2024
NCT03285230 Active, not recruiting The French E3N Prospective Cohort Study June 15, 1990 December 15, 2025
NCT03266484 Active, not recruiting N/A Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease November 13, 2017 July 2024
NCT03261206 Active, not recruiting Phase 4 Stopping Aminosalicylate Therapy in Inactive Crohn's Disease November 20, 2017 June 2026
NCT05463900 Active, not recruiting Microbial and Human Determinants of the Onset of IBD Flares August 1, 2022 July 2025
NCT03162432 Active, not recruiting Phase 3 High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade August 1, 2017 December 1, 2023
NCT06324591 Active, not recruiting N/A Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease Patients February 3, 2021 December 31, 2024
NCT02770599 Active, not recruiting Improving the Health Care in Inflammatory Bowel Disease. May 15, 2016 July 20, 2025
NCT02131168 Completed Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study January 2011 March 2021
NCT02135289 Completed The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID March 2012 July 31, 2019
NCT02161640 Completed Vascular Dysfunction in Paediatric IBD September 2014 January 2017
NCT02227602 Completed N/A Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease January 2014 March 2018
NCT02321280 Completed Phase 1/Phase 2 The Efficacy of Denosumab in Active Crohn's Disease February 2015 April 20, 2018
NCT02330653 Completed Phase 1/Phase 2 Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis November 2015 April 8, 2019
NCT02343601 Completed Phase 3 Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery December 2014 December 2016
NCT02349594 Completed Phase 4 Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease January 2014 September 2015
NCT02367183 Completed Phase 1 A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease April 8, 2015 December 14, 2017
NCT02394028 Completed Phase 3 A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease March 20, 2015 September 7, 2021
NCT02399683 Completed Immune Modulation From Trichuris Trichiura February 2012 December 2012
NCT02445547 Completed Phase 1/Phase 2 Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease June 2012
NCT02472457 Completed N/A Crohn Disease Exclusion Diet After Single Medication De-escalation August 2015 September 2020
NCT02504255 Completed Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn's Disease April 2011 April 2014
NCT02513459 Completed Phase 2 A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease September 16, 2015 June 19, 2019
NCT02520843 Completed Phase 1/Phase 2 An Innovative Treatment for Fistula-in-ano in Crohn Disease : Local Micro Reinjection of Autologous Fat and SVF October 2015 February 2018
NCT02538354 Completed N/A The Effect of Riboflavin in Crohn's Disease March 2016 April 2017
NCT02539849 Completed N/A Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease December 2014 December 19, 2017
NCT02612103 Completed Biomarkers in Inflammatory Bowel Diseases November 2015 June 2019
NCT02646683 Completed Phase 4 A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study July 2015 May 26, 2023
NCT02727959 Completed Inflammatory Bowel Disease in South Eastern Norway January 1, 2017 December 31, 2019
NCT02764762 Completed Phase 4 Triple Combination Therapy in High Risk Crohn's Disease (CD) April 18, 2017 July 5, 2022
NCT02770495 Completed Phase 3 Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease January 2011 April 2016
NCT03171246 Completed N/A CD-TREAT Diet: a Novel Therapy for Active Luminal Crohn's Disease October 23, 2017 May 31, 2023
NCT00040521 Completed Phase 2 Study Evaluating rhIL-11 in Active Crohn's Disease April 2002 October 2003
NCT00056355 Completed Phase 1 Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease March 2003 November 2005
NCT00094458 Completed Phase 3 Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC March 2005 December 2009
NCT00102921 Completed Phase 2 Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease August 2004 December 2005
NCT00126373 Completed Phase 2/Phase 3 A Trial of Wellbutrin for Crohn's Disease May 2005 March 2006
NCT00206596 Completed Phase 2 Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease July 2003 October 2005
NCT00206674 Completed Phase 3 Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease September 2004 June 2006
NCT00207662 Completed Phase 3 A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease July 2000 November 2005
NCT00207675 Completed Phase 3 A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease February 2003 August 2007
NCT00207766 Completed Phase 3 A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease June 2000 August 2006
NCT00261976 Completed A Long-term Safety Study of Infliximab (Remicade) February 2002 March 2012
NCT00265122 Completed Phase 2 A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease April 2004 October 2006
NCT00269841 Completed Phase 3 An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease May 1996 February 1998
NCT00269854 Completed Phase 2/Phase 3 An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease June 1995 October 1996
NCT00364130 Completed N/A Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial February 2007 August 2012
NCT00468455 Completed Post-Op Quality of Life After Colorectal Surgery October 2005 May 2008
NCT00517296 Completed Phase 4 Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas January 2008 December 2015
NCT00521950 Completed N/A Cost-effectiveness of TPMT Pharmacogenetics September 2007 December 2011
NCT00552058 Completed Phase 3 Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease March 2008 November 2009
NCT00552344 Completed Phase 3 A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease May 2008 December 2014
NCT00571337 Completed Phase 3 Stop Infliximab in Patients With Crohn's Disease December 2005 July 2010
NCT00587210 Completed Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel June 2004 December 2008
NCT00723905 Completed Remicade Infusion Management Program August 2005 October 2012
NCT00829595 Completed N/A Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease May 2005 December 2007
NCT00976690 Completed Phase 3 Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease October 2002 December 2010
NCT00999115 Completed Phase 1/Phase 2 Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn's Disease (ALOREVA) September 2009 December 2011
NCT01090817 Completed Phase 2 An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease January 2010 June 2015
NCT01099111 Completed Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders July 2010 March 2012
NCT01157650 Completed Phase 1/Phase 2 Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue June 2010 September 2013
NCT01183845 Completed Phase 4 Evaluation of the Applicability of the CDEIS to Data Obtained by the Colonic Capsule Endoscopy in Crohn Disease April 2009 June 2012
NCT01218360 Completed Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484) November 2011 January 2015
NCT01233310 Completed Evaluation of Small Bowel Colon Capsule for Bowel Visualization in Crohn's Disease Patients October 2010 April 2012
NCT01233570 Completed Phase 2 Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease
NCT01301417 Completed Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis February 2011 August 2011
NCT01331551 Completed Mesalamine and Reproductive Health Study May 2010 August 2018
NCT01349920 Completed Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143) November 28, 2012 September 28, 2015
NCT01365767 Completed Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease May 2011 September 2011
NCT01473927 Completed Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease October 2011 June 2013
NCT01487759 Completed N/A Prebiotic Effect on Metabolites in Crohn's Disease March 2008 July 2009
NCT01656746 Completed N/A Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease May 2010 October 2013
NCT01738529 Completed N/A Characterization of Crohn's Disease at Confocal Laser Endomicroscopy (CLE) and Related to Disease Activity November 2012 February 2015
NCT01787825 Completed N/A Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease May 2012 February 2016
NCT01817426 Completed Phase 4 Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission January 2013 May 2020
NCT01861288 Completed Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease November 1, 2013 February 28, 2018
NCT01908283 Completed Phase 4 Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease March 2014 December 2016
NCT01990716 Completed N/A Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel Diseases February 2013 May 2015
NCT02020382 Completed N/A Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases December 2013 December 2017
NCT02031276 Completed Phase 2 Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease. February 2014 November 2016
NCT02060318 Completed Regulatory T-cells and Crohn's Disease February 11, 2014 March 7, 2016
NCT02085083 Completed N/A Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease July 2014 December 2017
NCT02851134 Completed Search for New Genetic Mutations Major Effect in Crohn's Disease April 2015 April 2018
NCT02871635 Completed Phase 3 BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity September 28, 2016 May 13, 2019
NCT02877134 Completed Phase 2 Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease August 25, 2016 January 24, 2022
NCT02899013 Completed Description of Perianal Lesions in a Cohort of Crohn's Disease Patients July 2015 December 2016
NCT02925338 Completed National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life October 19, 2016 April 12, 2021
NCT02925351 Completed Early Phase 1 Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases January 25, 2016 April 30, 2018
NCT02953275 Completed Early Phase 1 Synergistic Effect of Vedolizumab and Pentoxifylline April 13, 2017 June 13, 2019
NCT02968108 Completed Phase 1 A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease January 18, 2017 March 18, 2022
NCT02986724 Completed A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) January 4, 2017 August 31, 2020
NCT03009396 Completed Phase 3 Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease March 18, 2017 August 19, 2019
NCT03011593 Completed N/A Effect of UGIR in Adults With Compromised Gut Function and Malabsorption November 2015 June 2016
NCT03019016 Completed Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy August 2016 October 2017
NCT03027193 Completed Phase 1 A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccines ChAdOx2 HAV and MVA in Healthy Adult Volunteers March 15, 2017 January 16, 2020
NCT03051204 Completed OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome February 28, 2017 December 11, 2018
NCT03052465 Completed N/A Magnetic Resonance Imaging of Motility in Crohn's 2 November 16, 2015 March 7, 2017
NCT03058679 Completed N/A Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease September 29, 2017 March 1, 2020
NCT03064815 Completed N/A The SpACE Study - Small Bowel Crohn's Disease and Spondyloarthropathies June 2009 March 2016
NCT03074656 Completed N/A The Norwegian Drug Monitoring Study March 1, 2017 December 14, 2020
NCT03078803 Completed Phase 2 Fecal Transplant for Crohn's Disease March 28, 2017 August 29, 2022
NCT03079700 Completed Immune Modulation From Trichuris Suis August 1, 2012 December 31, 2012
NCT03090139 Completed Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets March 28, 2017 June 13, 2018
NCT03096379 Completed MRI Differentiating Gut TB and Crohn's December 30, 2014 March 30, 2019
NCT03107793 Completed Phase 3 Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab April 19, 2017 July 20, 2021
NCT03134586 Completed N/A Advanced Non-Invasive Diagnostics in Inflammatory Bowel Disease June 2016 October 23, 2020
NCT03143517 Completed Fecal Calprotectin Collection Protocol April 19, 2017 August 23, 2018
NCT03194529 Completed Phase 1/Phase 2 FMT in Pediatric Crohn's Disease October 9, 2017 July 31, 2019
NCT03220243 Completed Phase 1 Stem Cell Coated Fistula Plug in Patients With Crohn's RVF October 19, 2017 September 20, 2020
NCT03241368 Completed N/A Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease. December 21, 2017 June 20, 2019
NCT03262649 Completed Manitoba Inflammatory Bowel Disease Cohort Study March 1, 2002 October 1, 2016
NCT03267238 Completed Early Phase 1 Fecal Microbial Transplantation in Patients With Crohn's Disease June 16, 2017 February 15, 2022
NCT03282903 Completed The PRognostic Effect of Environmental Factors in Crohn's and Colitis November 1, 2016 March 20, 2022
NCT03301311 Completed N/A Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease April 10, 2018 September 8, 2020
NCT03329209 Completed Phase 1 A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants March 5, 2018 September 5, 2018
NCT03351647 Completed Predictive Factors of Clinical Response to Ustekinumab in Active Crohn's Disease February 14, 2018 September 23, 2019
NCT03359642 Completed N/A Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy June 5, 2018 September 16, 2021
NCT03378167 Completed Phase 1 PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial December 1, 2018 September 30, 2023
NCT03435016 Completed N/A A Comparative Study of MRI, US and CE for Assessing Treatment Response in Known Crohn's Disease February 1, 2018 June 1, 2023
NCT03439826 Completed Junior / Senior Concordance in Ultrasound Assessment of Crohn's Disease February 13, 2018 April 1, 2019
NCT03440385 Completed Phase 3 Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease March 7, 2018 November 21, 2023
NCT03449069 Completed Phase 1 Pediatric MSC-AFP Sub-study for Crohn's Fistula July 23, 2018 December 31, 2023
NCT03452501 Completed Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients August 26, 2018 August 17, 2020
NCT03464136 Completed Phase 3 Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year March 29, 2018 May 21, 2021
NCT03466515 Completed N/A Stem Cells Treatment of Complex Crohn's Anal Fistula June 1, 2018 December 31, 2020
NCT03476317 Completed Phase 2 Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease July 12, 2018 December 31, 2020
NCT03488030 Completed A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) December 12, 2018 May 31, 2019
NCT03495973 Completed Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease October 25, 2017 November 22, 2020
NCT03496818 Completed Effect of SB CD on Chylomicron April 16, 2018 June 1, 2020
NCT03508193 Completed N/A Reverse Engineering of Exclusive Enteral Nutrition November 4, 2017 January 5, 2022
NCT03512327 Completed N/A Autoimmune Protocol Diet and Inflammatory Bowel Disease September 1, 2016 December 10, 2016
NCT03532932 Completed A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice July 20, 2018 November 8, 2021
NCT03541733 Completed N/A Bowel Preparation for Magnetic Resonance Enterography June 1, 2018 February 28, 2023
NCT03546868 Completed Phase 2 Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease August 14, 2018 January 11, 2019
NCT03553472 Completed Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster January 1, 2018 May 31, 2019
NCT03555773 Completed N/A Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas May 11, 2016 June 28, 2017
NCT03565432 Completed Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases March 9, 2018 February 19, 2020
NCT03574948 Completed Phase 2 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores December 6, 2018 March 3, 2021
NCT03606499 Completed Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases September 26, 2018 March 17, 2023
NCT03668249 Completed A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD) September 26, 2018 September 16, 2019
NCT03670693 Completed N/A Non-invasive Approaches to Identify the Cause of Fatigue in Inflammatory Bowel Disease Patients. August 1, 2018 January 5, 2022
NCT03671980 Completed N/A IBD Self-management Website and Home Faecal Calprotectin Monitoring April 4, 2017 June 30, 2018
NCT03681067 Completed Phase 1/Phase 2 A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease February 20, 2019 June 2, 2020
NCT03691155 Completed N/A The Feasibility of Following the Crohn's Diet July 8, 2018 December 18, 2018
NCT03709628 Completed Phase 1 A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients March 7, 2018 December 4, 2019
NCT03710486 Completed A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants February 19, 2019 February 21, 2022
NCT03723447 Completed Phase 4 Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) October 23, 2018 October 29, 2019
NCT03752970 Completed Phase 2 A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease February 5, 2019 July 4, 2022
NCT03755583 Completed N/A Effect of Exclusive Enteral Nutrition on Disease Process, Nutritional Status and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease February 1, 2017 December 31, 2019
NCT03774485 Completed Myoelectric GutPrint-Crohn's Disease January 1, 2019 June 15, 2023
NCT03782376 Completed Phase 3 A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease December 20, 2018 January 10, 2023
NCT03803917 Completed N/A Adipose Tissue in Crohn´s Disease Fistulas March 1, 2015 June 30, 2018
NCT03817983 Completed MRE as a Screening Tool for axSpA in IBD March 4, 2019 August 8, 2020
NCT03819257 Completed Anorectal Function in Perianal Crohn's Disease January 19, 2019 February 22, 2020
NCT03835780 Completed The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study February 1, 2019 December 1, 2019
NCT03836612 Completed Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease February 1, 2019 November 1, 2019
NCT03846778 Completed Risk Factors of Complications After Ileocolic Resection for Crohn Disease According to the Comprehensive Complication Index January 1, 2019 September 1, 2020
NCT03897400 Completed Ovarian Reserve in Crohn's Disease March 1, 2019 September 1, 2019
NCT03939117 Completed The IUSS Crohn's Study: A Feasibility Study January 19, 2019 March 9, 2020
NCT03941184 Completed Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity January 1, 1995 November 10, 2020
NCT03942120 Completed Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab) April 8, 2019 January 14, 2022
NCT03962998 Completed Early Phase 1 Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability October 27, 2019 October 5, 2021
NCT03964883 Completed Infliximab Blood Test in Crohn's Disease January 1, 2018 March 31, 2018
NCT03999294 Completed N/A Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel Disease April 1, 2015 January 31, 2017
NCT04018040 Completed N/A Vegetarian Diet in IBD May 6, 2019 August 10, 2023
NCT04018599 Completed Phase 1 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS July 15, 2019 March 17, 2020
NCT04065048 Completed N/A A Dietary Intervention Study on the Microbiome in Crohn's Disease Patients November 1, 2019 October 10, 2023
NCT04112212 Completed Phase 1 Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients November 4, 2020 January 1, 2023
NCT04151420 Completed Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment June 15, 2020 February 1, 2022
NCT04164849 Completed Phase 1/Phase 2 Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid November 22, 2019 October 31, 2023
NCT04188990 Completed N/A Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition June 15, 2020 June 30, 2023
NCT04191707 Completed Metabolomic Markers of Fatigue in Inflammatory Bowel Disease November 1, 2013 December 1, 2019
NCT04198831 Completed N/A Effect of Acupuncture on Quiescent Crohn's Disease April 1, 2015 December 31, 2023
NCT04213729 Completed N/A Diet Intervention for Crohn's Disease Patient November 26, 2019 February 20, 2024
NCT04225403 Completed N/A Telephone-based Motivational Interviewing for Smoking Cessation in Crohn's Disease Patients November 6, 2015 May 8, 2017
NCT04239521 Completed The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata October 1, 2020 November 28, 2022
NCT04272788 Completed Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease January 24, 2017 September 29, 2019
NCT04312659 Completed A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease July 15, 2020 September 12, 2023
NCT04321941 Completed Phase 2 Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent January 29, 2020 May 12, 2022
NCT04388865 Completed N/A Patient Automated Text Hovering for IBD February 23, 2021 January 10, 2023
NCT04567628 Completed Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes October 5, 2020 September 22, 2021
NCT04573959 Completed N/A Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System October 1, 2015 June 11, 2020
NCT04597905 Completed Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe October 21, 2020 January 31, 2021
NCT04606017 Completed Effect of Vitamin D Supplementation on Infliximab Response in Patients With Crohn's Disease January 1, 2014 June 1, 2020
NCT04637399 Completed Circadian Misalignment in Inflammatory Bowel Disease November 22, 2016 November 2021
NCT04643496 Completed CRP Monitoring After ICR in CD Patients January 1, 2010 September 1, 2020
NCT04682522 Completed Phase 4 Flagyl Microbiome in Crohn's Disease March 21, 2021 August 15, 2023
NCT04739579 Completed Post-operative CRP Trend After Ileocolic Resection in Crohn's Disease Patients. January 27, 2021 March 1, 2021
NCT04754620 Completed N/A Distant Management of Crohn's Disease by Smartphones is Feasible and Effective Additionally it Reduces the Costs March 1, 2020 September 1, 2020
NCT04757935 Completed N/A Yoga for Youth With IBD: a Pilot Feasibility Study January 1, 2017 May 31, 2017
NCT04775732 Completed Phase 4 Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease June 1, 2018 September 30, 2019
NCT04804540 Completed Phase 4 A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease December 29, 2021 February 2, 2024
NCT04809194 Completed Stress in Crohn's Disease September 1, 2019 June 30, 2022
NCT04828031 Completed Phase 1 Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease July 1, 2021 July 1, 2023
NCT04844593 Completed A Study Using Artificial Intelligence to Identify Adults With Complex Perianal Fistulas Associated With Crohn's Disease March 8, 2022 April 29, 2024
NCT04861597 Completed N/A Digital Behavioral Interventions in Inflammatory Bowel Disease November 1, 2021 March 22, 2023
NCT04873700 Completed A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD) August 30, 2021 May 17, 2022
NCT04876690 Completed A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas July 9, 2021 May 27, 2022
NCT04877990 Completed Phase 2 A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis May 7, 2021 August 29, 2023
NCT04909359 Completed Characterization of CD Responders to Vedolizumab August 25, 2015 May 18, 2020
NCT04924543 Completed N/A OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD July 7, 2021 April 30, 2022
NCT05034159 Completed N/A CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease October 22, 2021 April 19, 2023
NCT05051943 Completed A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response September 29, 2020 January 20, 2023
NCT05056441 Completed A Study of Real-World Outcomes of People With Crohn's Disease (CD) December 1, 2021 September 30, 2022
NCT05098600 Completed The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic October 15, 2021 December 20, 2022
NCT05117996 Completed N/A Simplified Bowel Preparation Versus Standard Bowel Preparation Before Capsule Endoscopy in Patients With Crohn's Disease July 5, 2022 April 22, 2024
NCT05161442 Completed Minimally Invasive Surgery in Crohn's Disease: Laparoscopic vs Robotic January 2014 June 1, 2023
NCT05172557 Completed N/A IBD and Women's Health Wellness Program April 14, 2022 December 26, 2023
NCT05182645 Completed N/A Effect of a Stress Reduction and Lifestyle Modification Programme on the Quality of Life of Crohn's Disease Patients July 1, 2020 March 31, 2022
NCT05322057 Completed Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease October 1, 2018 December 1, 2021
NCT05458531 Completed Monitoring of Inflammatory Conditions June 28, 2022 February 8, 2023
NCT05500040 Completed Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation August 9, 2022 July 26, 2023
NCT05504915 Completed Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek May 1, 2022 May 31, 2023
NCT05506787 Completed Phase 4 The Effects of Intraoperative Esketamine on Postoperative Pain and Mood in Patients With Inflammatory Bowel Disease September 1, 2020 March 1, 2022
NCT05635292 Completed N/A Addressing Disability Effectively With Psychosocial Telemedicine February 15, 2023 January 3, 2024
NCT05642247 Completed Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging Science July 1, 2022 January 31, 2023
NCT05768971 Completed Contrast-enhanced Ultrasound in Patients With Crohn´s Disease and Food Allergy December 6, 2012 November 14, 2014
NCT05796245 Completed A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis December 1, 2023 March 14, 2024
NCT05807971 Completed Phase 1 Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects April 6, 2023 February 8, 2024
NCT05874349 Completed Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease June 1, 2017 January 1, 2023
NCT05927064 Completed Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients July 21, 2023 January 12, 2024
NCT06023667 Completed N/A SMART-IBD App Trial December 14, 2022 December 28, 2023
NCT06069167 Completed Bowel Urgency in Inflammatory Bowel Disease October 12, 2023 March 22, 2024
NCT06352164 Completed N/A Efficacy Classification Prediction of the Effects of Acupuncture on Abdominal Pain in Patients With Crohn's Disease March 1, 2015 March 31, 2024
NCT06364722 Completed N/A Effect of Acupuncture on the Microbiota-gut-brain Axis in Crohn's Disease May 1, 2015 March 28, 2024
NCT06375382 Completed N/A Effects of Acupuncture on Abdominal Pain-related Intestinal Flora in Patients With Crohn's Disease March 1, 2015 March 31, 2024
NCT06441526 Completed Phase 3 Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design September 14, 2013 June 7, 2021
NCT06446219 Completed Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease January 1, 2020 March 31, 2024
NCT06448819 Completed N/A Real-life Use of the Crohn's Disease Exclusion Diet (CDED) in Adult Patients With Crohn's Disease January 20, 2023 August 31, 2023
NCT05994716 Enrolling by invitation N/A Telemonitoring for IBD Goodness Examination in Russia April 25, 2023 October 30, 2024
NCT04646187 Enrolling by invitation Phase 4 De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease March 11, 2021 March 2025
NCT06146335 Enrolling by invitation N/A Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery January 3, 2024 December 2035
NCT04113733 Enrolling by invitation Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas December 17, 2019 February 2027
NCT04835506 Enrolling by invitation Phase 4 Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial November 1, 2021 December 31, 2024
NCT06381518 Enrolling by invitation N/A Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease March 12, 2024 May 1, 2025
NCT03362736 No longer available An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease
NCT06165289 Not yet recruiting N/A Endoscopic Balloon Dilatation Combined With PRP Injection in Colonic Stenosis in Crohn's Disease December 15, 2023 December 31, 2026
NCT04647578 Not yet recruiting Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis December 2022 July 2024
NCT06432764 Not yet recruiting Phase 1 Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease. August 30, 2024 February 13, 2026
NCT06197334 Not yet recruiting N/A Gastro-intestinal Biopotential Recorder by Means of Surface ELEctrodes March 1, 2024 September 1, 2025
NCT06315179 Not yet recruiting Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) April 2024 January 2030
NCT06419335 Not yet recruiting Early Phase 1 Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study June 1, 2024 December 1, 2025
NCT05284136 Not yet recruiting Phase 2/Phase 3 Exclusion Diet vs corticosteroIds in patientS With activE Crohn's Disease April 1, 2022 April 1, 2026
NCT04398836 Not yet recruiting Phase 3 Preoperative Nutrition for Crohn's Disease Patients September 2020 December 2027
NCT06453720 Not yet recruiting Predicting IBD Treatment Outcomes With Gut Microbiome Analysis June 7, 2024 December 7, 2025
NCT06089590 Not yet recruiting Ibd CAncer and seRious Infections in France (I-CARE 2) November 15, 2023 March 1, 2031
NCT06203782 Not yet recruiting Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Strictures January 1, 2024 January 1, 2026
NCT05659953 Not yet recruiting Phase 1 LMT503 First-in-human SAD, MAD, and FE Study April 1, 2024 March 1, 2025
NCT05407350 Not yet recruiting Validation of an IUS Activity Index June 2022 June 2025
NCT05698745 Not yet recruiting Immunological Characteristics of Preclinical IBD(EARLY) May 1, 2024 May 1, 2038
NCT05719766 Not yet recruiting N/A Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients April 1, 2023 February 1, 2027
NCT05689892 Not yet recruiting N/A Shared Decision Making in Paediatric Inflammatory Bowel Disease January 2024 December 2025
NCT06424769 Not yet recruiting N/A Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management May 2024 September 2028
NCT06439641 Not yet recruiting N/A Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel Disease July 2024 September 2025
NCT06301477 Not yet recruiting N/A PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial April 1, 2024 March 1, 2027
NCT05725876 Not yet recruiting Phase 1 Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis. July 1, 2023 June 30, 2025
NCT05972694 Not yet recruiting N/A Effect of Grapes in Inflammatory Bowel Disease July 2, 2024 November 2, 2025
NCT05230160 Not yet recruiting N/A Can Intermittent Fasting Induce Weight Loss and Improve Gut Health as Compared to Standard Medical Care in Patients With Obesity/High BMI and Crohn's Disease. March 1, 2022 June 30, 2025
NCT06257706 Not yet recruiting Phase 4 VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease February 26, 2024 September 6, 2028
NCT05974280 Not yet recruiting Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells January 2024 June 2025
NCT04779762 Not yet recruiting N/A Stelara and Diet Trial for Crohn"s Disease January 2022 January 2026
NCT06298461 Not yet recruiting Phase 4 Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. May 2024 June 2025
NCT05332639 Not yet recruiting N/A Personalized Risk Estimation for Crohn's Disease (PRE-CD): Implementation and Feasibility February 2025 August 2026
NCT06388057 Not yet recruiting N/A Intraoperative Ultrasound in Crohn's Disease August 1, 2024 September 1, 2025
NCT05835973 Not yet recruiting N/A Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients. May 1, 2024 September 1, 2026
NCT05584228 Not yet recruiting N/A Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease April 1, 2023 October 1, 2027
NCT06338930 Not yet recruiting N/A Remote Monitoring of Patients With an Inflammatory Bowel Disease Under no or Maintenance Therapy July 1, 2024 March 30, 2027
NCT05636657 Not yet recruiting Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease November 30, 2022 May 31, 2025
NCT06298188 Not yet recruiting N/A Risankizumab in Children With Crohn's Disease (RisaKids) March 2024 October 2026
NCT06426316 Not yet recruiting N/A The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. May 15, 2024 April 30, 2027
NCT06250361 Not yet recruiting Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease February 15, 2024 June 15, 2025
NCT05523050 Not yet recruiting N/A Active Surgical Intervention on Crohn's Disease September 16, 2022 May 16, 2024
NCT05974358 Not yet recruiting N/A KONO-S Anastomosis Compared to Conventional Ileocolonic Anastomosis to Reduce Recurrence in Crohn's Disease April 1, 2024 January 31, 2028
NCT05842564 Not yet recruiting N/A Autophagy in Paediatric Crohn's Disease June 2023 September 2025
NCT05813860 Not yet recruiting Phase 4 HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease April 30, 2023 October 31, 2026
NCT06073288 Not yet recruiting Unveiling the Microbial Impact on Intestinal Fibrosis November 1, 2023 November 1, 2026
NCT05615116 Not yet recruiting Clinical Study on the Distribution of Digestive Tract Microbiota Before and After Ileocecal Resection in Crohn's Disease November 15, 2022 March 15, 2023
NCT05482932 Not yet recruiting Health-related Physical Fitness in Patients With Inflammatory Bowel Disease August 1, 2022 April 1, 2024
NCT05944068 Recruiting N/A The Effects of a Mindfulness Based Intervention on IBD Disability March 6, 2024 June 30, 2025
NCT04160325 Recruiting N/A Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery January 1, 2018 October 31, 2023
NCT05635266 Recruiting Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives October 26, 2021 October 2025
NCT04178408 Recruiting IBD Registry in a Sub-Saharan African Population January 2, 2021 December 31, 2025
NCT04186247 Recruiting Phase 2 Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD) August 13, 2021 December 2023
NCT04187820 Recruiting N/A Effect of Acupuncture on Mild to Moderate Active Crohn's Disease June 1, 2019 December 31, 2024
NCT05956158 Recruiting N/A RISE: A Remote Study of Insomnia Treatment in Crohn's Disease November 28, 2023 May 15, 2026
NCT05633706 Recruiting Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis January 9, 2023 January 1, 2025
NCT04191395 Recruiting Evolution and Treatments of Chronic Inflammatory Systemic Diseases December 11, 2019 December 2029
NCT04192825 Recruiting Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease February 3, 2020 August 3, 2028
NCT04200547 Recruiting N/A Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence January 29, 2020 September 1, 2024
NCT05627128 Recruiting N/A A Culturally Tailored Dietary Intervention to Treat Crohn's Disease September 6, 2022 October 30, 2025
NCT04211129 Recruiting N/A Effect of Acupuncture on Patients With Crohn's Disease in Remission July 1, 2019 December 31, 2024
NCT04223518 Recruiting Early Phase 1 Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD) September 20, 2020 May 31, 2023
NCT04224558 Recruiting Phase 1/Phase 2 Stem Cell Transplantation in Crohn's Disease December 15, 2020 January 1, 2025
NCT05805020 Recruiting N/A Cellvizio to Evaluate Margins in Crohn's Ileal Disease March 3, 2022 March 2025
NCT05606419 Recruiting N/A The Crohn's Disease Exclusion Diet With Early Dairy Introduction Plus Partial Enteral Nutrition for Crohn's Disease January 10, 2023 September 2025
NCT04239248 Recruiting N/A "Tasty&Healthy" Dietary Approach for Crohn's Disease April 1, 2020 May 2024
NCT05998577 Recruiting N/A A Personalized Approach to Abdominal Pain in Irritable Bowel Syndrome May 19, 2023 May 19, 2025
NCT02103361 Recruiting Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project November 2013 December 2025
NCT04254549 Recruiting Phase 2 Rifaximin in Patients With Diabetic Gastroparesis June 14, 2019 December 2024
NCT04263831 Recruiting Phase 1/Phase 2 Low Dose IL-2 for the Treatment of Crohn's Disease March 11, 2021 December 31, 2025
NCT04266600 Recruiting N/A Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease September 27, 2019 September 27, 2024
NCT05598684 Recruiting SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases November 24, 2022 December 30, 2025
NCT05598489 Recruiting Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease December 7, 2022 July 31, 2024
NCT04283864 Recruiting Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease November 29, 2020 December 2025
NCT04303260 Recruiting N/A Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease July 8, 2019 December 2025
NCT05587673 Recruiting Phase 1 High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD) October 6, 2022 December 2026
NCT06030882 Recruiting N/A Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway March 25, 2024 March 2025
NCT03261102 Recruiting N/A TDM Guided Early Optimization of ADAL in Crohn's Disease January 17, 2017 June 1, 2024
NCT05578313 Recruiting Inflammatory Bowel Diseases (IBD) Cannabis Registry July 10, 2019 July 10, 2024
NCT04330846 Recruiting N/A Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease. November 29, 2022 April 1, 2027
NCT04331639 Recruiting Phase 2 High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy November 1, 2020 September 2024
NCT05578235 Recruiting N/A Comparing Hand-sewn (END-TO-END or Kono-S) to Stapled Anastomosis in Ileocolic Resection for Crohn's Disease July 13, 2023 October 1, 2027
NCT03219359 Recruiting Phase 2 Autologous Stem Cell Transplant for Crohn's Disease July 12, 2017 October 2030
NCT03185000 Recruiting Phase 1 Treg Immunotherapy in Crohn's Disease August 8, 2022 June 30, 2025
NCT03183661 Recruiting A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial November 16, 2016 December 31, 2026
NCT04372108 Recruiting A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis June 24, 2021 August 30, 2030
NCT06042387 Recruiting Diverse Ancestry Study in IBD May 1, 2022 September 2027
NCT04431700 Recruiting N/A Study of Dietary Composition in Crohn's Disease October 5, 2020 May 1, 2025
NCT03808103 Recruiting Phase 1/Phase 2 Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease May 1, 2019 September 30, 2024
NCT05572008 Recruiting N/A ProteIn Nutrition in Crohn's Disease July 20, 2022 May 25, 2023
NCT05554445 Recruiting Observational Investigation of the CDED in a Real World IBD Clinic February 21, 2022 December 1, 2024
NCT05552287 Recruiting Phase 4 Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease August 2, 2023 January 2025
NCT04508088 Recruiting Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease September 10, 2020 December 2024
NCT05542459 Recruiting Multi-omics to Predict Responses to Biologics in IBD January 1, 2020 November 1, 2024
NCT05542355 Recruiting Phase 1 EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease March 20, 2023 October 2025
NCT05521867 Recruiting N/A Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Strictures February 10, 2023 February 9, 2026
NCT05521672 Recruiting Phase 1/Phase 2 Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease October 24, 2022 June 1, 2025
NCT04539665 Recruiting N/A Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease. September 27, 2019 June 30, 2024
NCT05519904 Recruiting Prevalence of Encephalopathy in Patients With Inflammatory Bowel Diseases October 1, 2022 August 31, 2023
NCT06051253 Recruiting Phase 4 TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease November 1, 2023 June 30, 2027
NCT06056986 Recruiting N/A Shear-Wave Elastography in Intestinal Fibrosis Evaluation in Crohn's Disease June 18, 2020 December 2024
NCT04578392 Recruiting N/A MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES) July 28, 2020 December 31, 2027
NCT04590508 Recruiting Phase 2 A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease October 1, 2020 September 30, 2024
NCT06065228 Recruiting Therapeutic Endpoint in Pediatric IBD Conditions November 27, 2023 December 2025
NCT04617184 Recruiting Registry and Biorepository for IBD in Central Texas June 1, 2021 December 31, 2030
NCT05502965 Recruiting N/A Specific Dietary Pattern for Crohn's Disease Patients Following Surgery September 17, 2022 June 30, 2024
NCT06324513 Recruiting N/A Evaluation of the Efficacy and Tolerability of the Mediterranean Diet Pattern in the Exclusion Diet for Patients With Crohn's Disease. July 27, 2023 October 27, 2025
NCT05499130 Recruiting Phase 2 A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease August 29, 2022 January 15, 2025
NCT04637438 Recruiting N/A Fecal Microbiota Transplantation in Postoperative Crohn's Disease May 18, 2021 December 2027
NCT05470985 Recruiting Phase 2/Phase 3 A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy August 22, 2023 March 16, 2032
NCT05469607 Recruiting N/A The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD July 8, 2022 July 2028
NCT05432934 Recruiting Phase 1/Phase 2 Transversus Abdominis Plane Blocks With and Without Dexamethasone September 1, 2022 August 31, 2024
NCT04663971 Recruiting Fertility and Pregnancy After Surgery IBD Audit February 1, 2024 October 1, 2024
NCT05421455 Recruiting N/A Surgery Versus Biologics for Stricturing CD--a RCT June 9, 2022 June 2030
NCT05420233 Recruiting N/A The CROCO Study: CROhn's Disease COhort Study August 1, 2021 August 2028
NCT05394272 Recruiting N/A Efficacy of Energy Therapy in the Management of Chronic Pain Medical Condition in Children and Adolescents. June 15, 2022 June 16, 2025
NCT05387031 Recruiting Efficacy of Ustekinumab-based Integrated Medicine Therapy in Patients With Symptomatic Stricturing Crohn's Disease May 26, 2022 June 2025
NCT05382897 Recruiting Early Phase 1 Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD July 1, 2022 December 2024
NCT06094608 Recruiting N/A IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms February 1, 2024 May 31, 2026
NCT04740541 Recruiting N/A Threonine Requirement in Adult Males With Crohn's Disease Using IAAO February 2, 2024 December 2025
NCT04748627 Recruiting Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st Century October 1, 2021 December 2023
NCT04751396 Recruiting Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors April 20, 2022 April 15, 2025
NCT06095596 Recruiting N/A Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis November 1, 2023 October 31, 2026
NCT06107179 Recruiting Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography January 24, 2024 February 1, 2026
NCT05377840 Recruiting N/A Use of Cognitive Behavioral Therapy (CBT) or Sudarshan Kriya Yoga (SKY) for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD) July 5, 2022 December 2024
NCT05333978 Recruiting N/A Optoacoustic Detection of Inflammation Using MSOT Device May 31, 2022 December 31, 2024
NCT05330416 Recruiting N/A Comparison of Quality of Life With or Without Automatic Seton Placement in Perianal Crohn's Fistula May 25, 2022 May 24, 2025
NCT04799496 Recruiting A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis June 10, 2020 January 14, 2026
NCT04803916 Recruiting Pre-stenotic Inflammation Following Endoscopic Balloon Dilatation in Crohn's Disease: A Prospective Study November 1, 2020 March 2025
NCT06116331 Recruiting The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD April 1, 2023 December 31, 2024
NCT06116604 Recruiting Early Bowel Resection for Terminal Ileal Crohn's Disease September 7, 2023 November 30, 2025
NCT04827368 Recruiting Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease March 22, 2021 September 30, 2025
NCT06117423 Recruiting Phase 1/Phase 2 Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease March 2024 June 2025
NCT06125678 Recruiting N/A Correlation of Cross Sectional Imaging and Small Intestinal Contrast Ultrasonography in Known Crohn's Disease July 20, 2023 September 19, 2024
NCT04846959 Recruiting Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications July 30, 2021 January 1, 2033
NCT04859088 Recruiting N/A Biologics and Partial Enteral Nutrition Study September 20, 2021 September 2026
NCT05321758 Recruiting N/A Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease March 22, 2020 June 30, 2025
NCT05321745 Recruiting N/A Fecal Microbiota Transplantation in Pediatric Crohn's Disease March 22, 2022 May 31, 2026
NCT06146816 Recruiting N/A The Assessment of Infrared Treatment for Crohn's Disease September 12, 2023 April 2026
NCT06152289 Recruiting Development of New Diagnostic Tools in Capsule Endoscopy February 10, 2023 February 2028
NCT05316584 Recruiting N/A A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy September 6, 2022 December 31, 2024
NCT05299931 Recruiting Phase 3 An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients With Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study September 10, 2021 December 2025
NCT05294107 Recruiting N/A Intestinal Organoids September 6, 2022 September 2024
NCT03809728 Recruiting N/A IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE December 10, 2019 December 10, 2034
NCT04912999 Recruiting Inflammatory Bowel Diseases Remission Registry August 1, 2019 May 1, 2026
NCT04913467 Recruiting N/A Effect of Ileocolonic Delivered Vitamins and an Anti-Inflammatory Diet on Crohn's Disease and Healthy Volunteers October 8, 2021 July 1, 2025
NCT04921033 Recruiting Phase 3 Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease March 1, 2021 January 1, 2026
NCT04923100 Recruiting Therapeutic Effect of New Biologics in Crohn's Disease June 10, 2021 March 29, 2025
NCT04924270 Recruiting Phase 2 Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases December 13, 2023 December 31, 2026
NCT05262829 Recruiting N/A Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease February 28, 2022 January 31, 2025
NCT05254886 Recruiting N/A Identification and Management of Comorbidities and Extra-intestinal Manifestations in Crohn's Disease: the NEMO Nurse-led Program December 12, 2022 January 1, 2027
NCT05253378 Recruiting Development and Validation of a Comorbidity Index in Crohn's Disease April 4, 2022 March 1, 2025
NCT05246917 Recruiting N/A Comparing Manual Versus Stapled Side to Side Ileocolic Anastomosis in Crohn's Disease May 25, 2022 December 31, 2024
NCT04966585 Recruiting Phase 4 Pilot Study of Posaconazole in Crohn's Disease August 17, 2022 December 31, 2025
NCT04970446 Recruiting Phase 2/Phase 3 Microbial Restoration in Inflammatory Bowel Diseases December 1, 2021 December 1, 2025
NCT05239702 Recruiting Early Phase 1 Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases February 28, 2022 December 1, 2024
NCT04973423 Recruiting N/A STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP March 21, 2022 August 21, 2027
NCT04974099 Recruiting Phase 2/Phase 3 Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease October 1, 2021 August 1, 2024
NCT05230875 Recruiting Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial April 7, 2022 September 5, 2023
NCT05230173 Recruiting N/A Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission October 5, 2022 June 1, 2028
NCT04997733 Recruiting Phase 3 Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal September 22, 2021 July 22, 2027
NCT04998084 Recruiting Advanced Therapy Registry of IBD Patients February 28, 2019 June 27, 2025
NCT05009212 Recruiting N/A Endoscopic Stricturotomy Versus Endoscopic Balloon Dilatation in Patients With Crohn's Disease and Symptomatic Small Bowel Stricture August 1, 2021 December 31, 2025
NCT05180175 Recruiting Phase 4 The Nordic IBD Treatment Strategy Trial February 7, 2022 July 10, 2024
NCT06206811 Recruiting Phase 1 Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants February 12, 2024 October 2025
NCT05040464 Recruiting Phase 3 Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial August 26, 2021 March 2024
NCT05043870 Recruiting Phase 4 Combined Immunosuppression for Pediatric Crohn's Disease October 10, 2022 December 31, 2025
NCT06216899 Recruiting N/A Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial March 11, 2024 January 10, 2027
NCT06221254 Recruiting N/A A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease August 1, 2023 August 1, 2026
NCT05174208 Recruiting Study of Imaginomics Predicting Early Surgical Rates in Crohn's Disease January 1, 2022 December 20, 2024
NCT05092269 Recruiting Phase 3 A Long-term Extension Study of Ustekinumab in Pediatric Participants October 18, 2021 September 29, 2027
NCT05112497 Recruiting Mother-to-Infant Transfer of Bacteriome, Fungome, Virome, and Metabolome in Health and Crohn's Disease June 10, 2020 August 2025
NCT05169593 Recruiting Phase 4 Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy September 8, 2022 October 2030
NCT06252493 Recruiting Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer. December 19, 2023 December 19, 2025
NCT05130983 Recruiting Phase 1 Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease January 23, 2023 September 1, 2024
NCT05165108 Recruiting N/A Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study November 30, 2021 December 31, 2024
NCT03816345 Recruiting Phase 1 Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer July 16, 2019 August 31, 2024
NCT05824962 Recruiting A Non-invasive Diagnostic Model for Intestinal Fibrosis in Crohn's Disease Based on 18F-FAPI PET Imaging January 1, 2023 December 31, 2025
NCT03840928 Recruiting PatientSpot Formerly Known as ArthritisPower April 1, 2015 March 1, 2025
NCT05861167 Recruiting Phase 4 SIIT Based on UST CDST in Patients With CD June 1, 2023 June 1, 2024
NCT03847467 Recruiting Phase 1/Phase 2 Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy September 20, 2019 March 2027
NCT03774329 Recruiting N/A Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease March 2, 2020 December 2023
NCT05781152 Recruiting Phase 4 Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease June 10, 2023 July 1, 2029
NCT05766566 Recruiting Treatment of Perianal Fistulas in Crohn's Disease With Autologous Microfragmented Adipose Tissue With the Lipogems System March 7, 2023 March 1, 2025
NCT03885713 Recruiting Phase 4 Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease September 10, 2019 December 31, 2024
NCT05722236 Recruiting N/A IBD Strong Peer2Peer for Self-Management of Psychological Distress June 1, 2023 March 2025
NCT06392061 Recruiting N/A Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease April 1, 2024 June 30, 2024
NCT03681652 Recruiting Post-Operative Crohn's Disease Outcome in Children February 11, 2019 March 1, 2027
NCT05721794 Recruiting Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort Study July 18, 2022 June 6, 2024
NCT05713409 Recruiting Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients February 10, 2022 May 1, 2025
NCT03915262 Recruiting Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease November 15, 2019 November 15, 2024
NCT03917303 Recruiting Phase 4 Control Crohn Safe Trial December 23, 2019 September 2026
NCT03935451 Recruiting Early Phase 1 Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease September 1, 2021 February 1, 2026
NCT05886322 Recruiting Remote Monitoring of IBD June 7, 2022 June 2024
NCT05891756 Recruiting Mesenteric Bacterial Translocation in Evolved Crohn's Disease July 1, 2022 December 2025
NCT05710276 Recruiting N/A Assessment of Intestinal Inflammation by Infrared Thermography in Pediatric Crohn Disease January 24, 2023 January 2024
NCT05903066 Recruiting TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1) October 11, 2023 August 2025
NCT05705856 Recruiting Effectiveness and Safety of Ustekinumab Intensification in Crohn's Disease February 15, 2023 June 1, 2024
NCT03944447 Recruiting Phase 2 Outcomes Mandate National Integration With Cannabis as Medicine December 1, 2018 December 31, 2025
NCT03589183 Recruiting Gut Microbiome in Inflammatory Bowel Disease April 1, 2018 March 31, 2028
NCT05704413 Recruiting Digestive Biobank for Exploring Microbiota-host Interactions June 17, 2021 September 17, 2026
NCT05906576 Recruiting Phase 4 Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients September 21, 2023 February 2027
NCT03571373 Recruiting PIBD-SETQuality: the Inception Cohort and Safety Registry January 3, 2017 December 31, 2025
NCT03983473 Recruiting N/A Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. November 16, 2021 December 16, 2024
NCT05913817 Recruiting The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. January 9, 2023 November 13, 2024
NCT03999580 Recruiting Phase 3 The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 ) February 7, 2020 December 2024
NCT05686135 Recruiting N/A 90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients June 7, 2023 July 2024
NCT05673278 Recruiting Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study May 1, 2023 May 1, 2024
NCT04014413 Recruiting N/A Safety and Efficacy of Fecal Microbiota Transplantation July 15, 2019 October 31, 2030
NCT05668013 Recruiting Phase 2 A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease January 11, 2023 August 2, 2031
NCT05916274 Recruiting N/A Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory Bowel Disease in Children Through Biological Pathway Cyclic GMP-AMP Synthase (cGAS) - Stimulator of Interferon Genes (STING) May 31, 2023 June 2026
NCT05660746 Recruiting Phase 2/Phase 3 Precise Infliximab Exposure and Pharmacodynamic Control July 1, 2023 March 31, 2027
NCT05928039 Recruiting Phase 4 PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease October 25, 2023 December 31, 2028
NCT05658081 Recruiting N/A Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study December 8, 2022 December 2029
NCT05653011 Recruiting Predictors of Prognosis in IBD Patients March 11, 2013 December 31, 2024
NCT05651542 Recruiting N/A A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease March 14, 2023 March 31, 2025
NCT03467958 Recruiting Phase 3 An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease August 24, 2018 March 24, 2031
NCT05636709 Recruiting National GMA Post-market Clinical Follow-up Study (GRACE) January 11, 2022 December 31, 2025
NCT05940558 Recruiting Phase 2 Safety and Efficacy of MBF-118 in Patients With Crohn Disease April 12, 2023 April 2024
NCT03464097 Recruiting Phase 3 A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease June 27, 2018 March 24, 2026
NCT03458195 Recruiting N/A Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group December 10, 2009 December 2026
NCT04985981 Suspended The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study April 1, 2021 December 31, 2022
NCT04225819 Suspended N/A Adjunctive Treatment With Vitamin D3 in Patients With Active IBD October 1, 2020 April 1, 2027
NCT04306939 Suspended Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study November 1, 2014 December 1, 2025
NCT04456400 Suspended Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities February 3, 2021 April 2024
NCT04898530 Suspended Diet Patterns in IBD in Central Texas June 8, 2021 December 31, 2024
NCT03358706 Suspended Phase 1 A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis February 2, 2018 October 1, 2024
NCT00206700 Terminated Phase 2 Open-label Trial of Leukine in Active Crohn's Disease February 2003 December 2006
NCT00561548 Terminated N/A Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease May 2007 April 2009
NCT04629196 Terminated Phase 4 Induction Optimization With Stelara for Crohn's Disease February 16, 2022 January 17, 2024
NCT04626947 Terminated Phase 4 Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). October 30, 2021 May 31, 2024
NCT03798405 Terminated N/A Reactive vs. Proactive Pain Control in IBD January 1, 2019 July 1, 2022
NCT03218202 Terminated Stricture Definition and Treatment (STRIDENT) Observational Study. October 9, 2017 August 29, 2019
NCT04362254 Terminated Phase 2 A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials May 15, 2020 September 23, 2022
NCT02620007 Terminated Phase 2 Evaluation of Adherent Invasive E. Coli Eradication in Adult Crohn Disease December 2015 June 2022
NCT03537157 Terminated Phase 2 A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention November 16, 2017 July 29, 2020
NCT03221166 Terminated Phase 3 Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors February 27, 2018 July 31, 2020
NCT03943446 Terminated Phase 2 A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery August 4, 2020 August 25, 2022
NCT03235180 Terminated Phase 4 Ultrasound Evaluation of Crohn's Disease June 16, 2017 October 12, 2021
NCT01671579 Terminated N/A Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease March 2012 August 2017
NCT02247258 Terminated Phase 2 Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence. October 2005 May 2015
NCT01864616 Terminated N/A The Impact of Vitamin D on Disease Activity in Crohn's Disease July 2013 March 2015
NCT04102111 Terminated Phase 2 A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease September 23, 2019 December 22, 2021
NCT05579444 Terminated Systems Biology of Gastrointestinal and Related Diseases November 11, 2022 November 29, 2023
NCT03597971 Terminated Phase 1 HMPL004-6599 Phase I Dose-escalating Study March 20, 2018 November 19, 2018
NCT00206713 Terminated Phase 3 Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim July 2004 October 2006
NCT03656627 Terminated Phase 1 Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease June 27, 2019 March 18, 2021
NCT00206661 Terminated Phase 1/Phase 2 Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease December 2004 December 2006
NCT02743806 Terminated Phase 4 Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease August 1, 2016 January 3, 2023
NCT03994224 Terminated A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD February 18, 2019 August 29, 2022
NCT03291743 Terminated N/A The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives February 10, 2017 September 30, 2022
NCT03472690 Terminated Phase 2 QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease June 25, 2018 February 25, 2021
NCT02596893 Terminated Phase 3 Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease December 8, 2015 January 5, 2018
NCT00511329 Terminated Phase 2/Phase 3 Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease August 2007 May 2010
NCT04274010 Terminated N/A PANenteric Crohn's Capsule Versus Ileo-Colonoscopy and Scan Study December 15, 2020 October 21, 2022
NCT02403323 Terminated Phase 3 Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 June 8, 2015 October 9, 2023
NCT00705471 Terminated Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED) April 2005 September 2007
NCT00764699 Terminated Phase 2/Phase 3 Effect of Increlex® on Children With Crohn Disease October 2008 May 2010
NCT01378390 Terminated Phase 3 Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease December 2008 February 2010
NCT04232228 Terminated A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers February 7, 2020 April 4, 2022
NCT04881370 Terminated Quality of Life for Patients With Chronic Paediatric Onset Inflammatory Bowel Disease (IBD) October 9, 2020 June 28, 2021
NCT00317369 Terminated Phase 2 A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease May 2006 August 2007
NCT03378388 Terminated A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life February 13, 2018 February 15, 2019
NCT00297193 Terminated Phase 3 ASTIC Autologous Stem Cell Transplantation for Crohn's Disease June 2006 March 2017
NCT02327221 Terminated Phase 2 Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease December 2014 November 2016
NCT02128503 Terminated N/A Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease February 2013 October 16, 2015
NCT00295165 Terminated Phase 3 Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease January 2006 October 2006
NCT02768532 Terminated Phase 4 Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease July 1, 2016 January 23, 2023
NCT04102163 Terminated Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment January 26, 2021 May 26, 2021
NCT02209792 Terminated Phase 2 Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease October 2001
NCT03455751 Terminated N/A Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery April 17, 2018 January 9, 2019
NCT03169894 Terminated Phase 1 Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis July 14, 2017 October 12, 2021
NCT00038766 Terminated Phase 2 CNI-1493 for Treatment of Moderate to Severe Crohn's Disease June 2002 June 2003
NCT03172143 Terminated N/A Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease August 29, 2017 December 18, 2018
NCT04131322 Terminated Phase 4 Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. October 10, 2019 June 8, 2020
NCT01570348 Terminated Phase 2 Crohn's Allogeneic Transplant Study July 17, 2012 October 30, 2019
NCT05474742 Terminated N/A The Nori Health App April 25, 2022 September 1, 2022
NCT03108326 Unknown status Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease April 15, 2017 March 31, 2023
NCT03131414 Unknown status The IMAGINE-SPOR CIHR Chronic Disease Network October 1, 2017 June 1, 2023
NCT04488146 Unknown status Pain in Patients With Crohn Disease (PAINCD) October 2020 February 2021
NCT04467580 Unknown status N/A Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease September 1, 2020 May 2, 2023
NCT03150238 Unknown status Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building April 13, 2017 May 31, 2019
NCT03172377 Unknown status Phase 4 Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients May 3, 2017 October 2022
NCT03176875 Unknown status N/A Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease May 25, 2017 December 31, 2018
NCT04370535 Unknown status N/A PMA-Zeolite-Clinoptilolite Effects in Crohn Disease October 17, 2018 May 15, 2020
NCT04362735 Unknown status Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy August 1, 2020 April 1, 2021
NCT03185611 Unknown status Phase 3 Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease May 18, 2017 July 31, 2018
NCT03185624 Unknown status Phase 3 Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease July 25, 2017 July 31, 2018
NCT00383344 Unknown status Phase 2 Use of FDG PET/CT to Evaluate Crohn Disease September 2006 May 2007
NCT03220841 Unknown status Phase 4 Stricture Definition and Treatment (STRIDENT) Drug Therapy Study October 9, 2017 September 2021
NCT03222011 Unknown status N/A Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study October 9, 2017 February 2021
NCT03239704 Unknown status N/A Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease December 1, 2018 December 1, 2020
NCT04329481 Unknown status N/A The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients June 12, 2018 June 12, 2024
NCT04328922 Unknown status N/A Fecal Microbial Transplantation and Vedolizumab Treatment of Crohn's Disease July 3, 2018 January 2023
NCT02752360 Unknown status Phase 1 Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis April 2016 December 2018
NCT03272152 Unknown status Comprehensive DNA Methylation Profiling in Crohn's Disease January 1, 2017 September 30, 2017
NCT04305535 Unknown status N/A Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease February 13, 2020 June 2021
NCT03288961 Unknown status Self Screening Tool for Crohn's Perianal Fistula May 1, 2017 December 1, 2019
NCT03322488 Unknown status N/A Fistulodesis Pilot Study for Closure of Perianal Fistulae June 20, 2017 December 2020
NCT03327038 Unknown status N/A Addressing Depression and Anxiety Symptoms in Patients With Inflammatory Bowel Disease January 1, 2018 January 1, 2020
NCT02704624 Unknown status Phase 4 Effects of Supplementation of Vitamin D in Patients With Crohn's Disease December 2016 February 2022
NCT04273399 Unknown status N/A High-impact Exercise in Adults With Crohn's Disease March 2020 October 2021
NCT02445690 Unknown status Thrombin Generation in Crohn's Disease May 2015 April 2017
NCT04233463 Unknown status N/A The Effect of Oral Polymeric Diet Enriched With TGF-beta 2 (Modulen) on Clinical Response and Mucosal Healing in Adult Patients With Newly Diagnosed Crohn's Disease January 2020 June 2021
NCT03366090 Unknown status Immunological Profiles in Inflammatory Bowel Disease October 1, 2017 July 1, 2020
NCT03393247 Unknown status N/A The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD June 1, 2017 July 1, 2019
NCT04225689 Unknown status N/A The Intensive Post Exclusive Enteral Nutrition Study January 10, 2020 February 2024
NCT02634060 Unknown status N/A Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny June 2016 December 2018
NCT04189692 Unknown status Evolution of Fatigue in Patients With Inflammatory Bowel Disease January 7, 2020 December 7, 2020
NCT04135027 Unknown status Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease July 1, 2019 December 30, 2022
NCT02631967 Unknown status N/A Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease November 2015 November 2022
NCT04134065 Unknown status Early Phase 1 the Effect of Vitamin D in Crohn's Disease December 1, 2019 December 31, 2020
NCT03465215 Unknown status N/A Evaluation of Stricturing Crohn's Disease Using Digital Holographic Microscopy February 1, 2018 August 1, 2020
NCT04109300 Unknown status N/A Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease September 1, 2020 September 1, 2023
NCT03623932 Unknown status N/A Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease November 13, 2018 November 13, 2021
NCT05057832 Unknown status Determination of Ustekinumab Levels in Patients With Crohn's Disease May 1, 2021 February 1, 2022
NCT05190484 Unknown status bIosimilar of aDalimumab, an European evAluation April 30, 2022 April 30, 2024
NCT00653094 Unknown status N/A An Open Label, Prospective, One Arm, Feasibility, Study for The Use of Halevy Kit for the Treatment of Perianal Fistulas in Patients With Crohn's Disease June 2008 August 2009
NCT00609752 Unknown status Phase 4 Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease February 2008 January 2010
NCT01388257 Unknown status N/A Anal Crohn Fistula Surgery October 2011 March 2017
NCT01559142 Unknown status Phase 3 Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease November 2008 December 2012
NCT04965584 Unknown status Microflora and Metabolomics of Crohn's Disease Patients August 1, 2021 July 31, 2022
NCT04946448 Unknown status N/A COmbinAtion Therapy of dieT With biologicalS for Crohn's Disease: the OATS Study September 14, 2021 September 30, 2023
NCT04933214 Unknown status Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease May 12, 2021 December 12, 2021
NCT04915911 Unknown status Nutritional Status and Body Composition of Adult Patients With Crohn's Disease July 1, 2021 May 1, 2023
NCT04887428 Unknown status Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD) November 28, 2019 October 2021
NCT04882566 Unknown status Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease August 2021 April 2022
NCT05321485 Unknown status N/A The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD March 16, 2022 September 16, 2022
NCT04865484 Unknown status N/A Prospective Randomized Comparative Study of the Treatment of Multisegmental Fibrostenosing Crohn's Disease. March 12, 2021 December 31, 2023
NCT01629628 Unknown status Phase 3 Adalimumab for the Management of Post-operative Crohn's Disease (CD) July 2012 July 2016
NCT05350644 Unknown status Inflammatory Bowel Disease(IBD), Treatment Response February 8, 2022 January 14, 2024
NCT05354609 Unknown status N/A DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease April 26, 2022 May 2024
NCT04761952 Unknown status N/A N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease February 13, 2021 December 31, 2023
NCT04736368 Unknown status N/A Effect of EDIP Based Diet on CD Activity January 26, 2021 July 31, 2021
NCT05386290 Unknown status A Multicentered Prospective Cohort Study of Chinese IBD Patients July 9, 2020 December 2023
NCT04712032 Unknown status Phase 3 Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage Rates July 1, 2020 October 1, 2022
NCT04709445 Unknown status N/A Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses March 1, 2020 December 2021
NCT04695964 Unknown status N/A Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis February 1, 2019 January 2021
NCT05418062 Unknown status N/A Group ACT for CD Pain- a Feasibility Study January 11, 2023 February 2024
NCT02806206 Unknown status Phase 4 Prucalopride Prior to Small Bowel Capsule Endoscopy July 2016 May 2017
NCT04695184 Unknown status N/A Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis February 1, 2019 January 2021
NCT05427942 Unknown status Yuflyma® (Adalimumab), Patient Experience After Switching June 3, 2022 March 1, 2023
NCT02878395 Unknown status Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases September 2016 January 2021
NCT04655729 Unknown status Biomarkers to Predict and Monitor Response to Infliximab November 18, 2019 January 1, 2023
NCT02931799 Unknown status N/A Prevention of Readmissions at IBD Centres of Excellence October 1, 2018 December 2021
NCT02951650 Unknown status Phase 1/Phase 2 Long Term Observational Study of a Vagal Nerve Stimulation Device in Crohn's Disease January 2015 August 2018
NCT04654494 Unknown status Colorectal Cancer in Crohn's Disease July 1, 2020 January 2021
NCT02956538 Unknown status Early Phase 1 Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide October 2016 October 2018
NCT04653259 Unknown status N/A Digital Nutrition Therapy for Patients With IBD May 15, 2021 October 15, 2022
NCT02998827 Unknown status N/A Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients November 2016
NCT03003351 Unknown status Zurich Fistula Cohort Study January 2017 January 2019
NCT03012542 Unknown status N/A Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease January 2017 December 2019
NCT04623476 Unknown status N/A PAtophysiological, Nodal-based Approach for Crohn's Disease Excision November 16, 2020 April 30, 2021
NCT03054935 Unknown status Resting Energy Expenditure Evaluation in Subjects With Crohn's Disease July 1, 2016 June 30, 2018
NCT04596566 Unknown status N/A Modeling Patient Response to a Therapeutic Diet in Crohn's Disease February 20, 2020 June 12, 2023
NCT03072836 Unknown status N/A Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis March 6, 2017 December 15, 2020
NCT01880918 Unknown status A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing October 2012 July 2013
NCT02056418 Unknown status Phase 4 Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult January 2014 January 2016
NCT04519697 Unknown status Phase 1/Phase 2 Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease October 28, 2020 October 2022
NCT03088449 Unknown status Personalising Anti-TNF Therapy in Crohns Disease (PANTS) March 2013 July 30, 2019
NCT04519684 Unknown status Phase 1/Phase 2 Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease October 28, 2020 October 2022
NCT03091309 Unknown status N/A Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease October 1, 2017 October 1, 2020
NCT04519671 Unknown status Phase 1/Phase 2 Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease November 19, 2020 November 2022
NCT04502303 Unknown status Phase 2 18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease September 2020 September 2021
NCT04010526 Unknown status Phase 2 Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN's Fistulas. March 2020 October 2023
NCT00290524 Unknown status Phase 3 Early Alimentation Following Colorectal Surgery January 2006
NCT03952364 Unknown status The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States October 10, 2019 June 2022
NCT05072782 Unknown status Phase 4 Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) December 21, 2021 June 15, 2024
NCT03640637 Unknown status The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases October 18, 2018 August 2021
NCT03941418 Unknown status N/A Impact of Additional Treatment With Saccharomyces Boulardii on Quality of Life in Patients With Mild Forms of Ulcerative Colitis and Crohn Disease June 1, 2019 March 31, 2020
NCT03913572 Unknown status Treatment of Perianal Disease Using Adipose-derived Stem Cells September 27, 2018 July 26, 2021
NCT03905109 Unknown status Phase 2 Safety Evaluation of ABX464 in Patients With Moderate to Severe Active Crohn's Disease April 15, 2020 October 30, 2021
NCT03904212 Unknown status Phase 2/Phase 3 Adipose Tissue Injection in Perianal Fistulas in Crohn´s Disease March 27, 2019 March 1, 2024
NCT03901937 Unknown status Phase 4 The Effects of Parenteral ω-3 Polyunsaturated Fatty Acid on Postoperative Complications of Patients With Crohn's Disease March 1, 2019 March 1, 2021
NCT02341248 Unknown status Bacteria & Inflammation in the Gut (BIG) Study July 18, 2014 July 2018
NCT03878498 Unknown status Management of Anal Fistula of Crohn Disease June 19, 2018 September 19, 2019
NCT03718182 Unknown status Phase 4 Can Vitamin D Supplementation in People With Crohn's Disease Improve Symptoms as an Adjunct Therapy? September 17, 2019 December 31, 2020
NCT03872726 Unknown status Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease March 1, 2019 May 30, 2019
NCT03735355 Unknown status N/A Endoscopic Balloon Dilation vs Surgery to Treat Short Strictures in Fibrostenosing Crohns Disease: An RCT April 1, 2019 February 28, 2022
NCT03863886 Unknown status N/A Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis January 4, 2019 June 2022
NCT02403232 Unknown status Phase 2 Autologous Adipose-derived Stem Cells (ASCs) for the Treatment of Perianal Fistula in Crohn Disease: A Pilot Study December 2014 December 2018
NCT02575040 Unknown status Phase 3 Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease May 2015 May 2020
NCT03841045 Unknown status Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases September 14, 2016 December 2020
NCT03776825 Unknown status Permacol Paste in Perianal Crohn's Disease February 7, 2019 October 1, 2021
NCT03477032 Unknown status FMT in Inflammatory Bowel Disease June 1, 2018 December 31, 2019
NCT02629211 Unknown status N/A Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD June 2016 February 2017
NCT04100005 Unknown status A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease March 2, 2020 July 2023
NCT04079335 Unknown status A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD January 28, 2019 January 28, 2021
NCT02264275 Unknown status N/A Influence of Aerobic Exercise Training (AET) on Inflammatory Bowel Disease (IBD) in Children and Adolescents October 2014 March 2015
NCT04031482 Unknown status TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners October 2019 September 2023
NCT04014517 Unknown status N/A Effect of Peri-operative Immunonutrition on Recurrence and Infections in Crohn's Disease Patients March 1, 2020 October 1, 2022
NCT04011943 Unknown status N/A Fecal Microbiota Transplantation for Health Improvement (TFM3) May 21, 2018 December 1, 2020
NCT03467620 Withdrawn Phase 2/Phase 3 Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease July 2018 July 2019
NCT00286689 Withdrawn N/A Effects of Growth Hormone in Chronically Ill Children February 3, 2006 February 3, 2006
NCT00354367 Withdrawn Phase 3 Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas January 2007
NCT02760615 Withdrawn Phase 4 Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study November 1, 2016 August 1, 2020
NCT03953794 Withdrawn Inflammatory Bowel Disease Tracker (IBD Tracker) October 2019 February 2021
NCT03712826 Withdrawn N/A Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease July 24, 2022 July 24, 2022
NCT01836289 Withdrawn Phase 1/Phase 2 High-dose Cyclophosphamide for Severe Refractory Crohn Disease March 2015 March 2018
NCT04349449 Withdrawn ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice September 30, 2020 November 30, 2022
NCT03059849 Withdrawn Phase 4 Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD February 1, 2018 September 1, 2019
NCT02820493 Withdrawn Phase 4 Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNF September 2016 March 2019
NCT03747718 Withdrawn Phase 1 Randomized Trial Comparing Single vs. Maintenance Fecal Microbiota Transplant for Refractory Crohn's Disease in Children December 1, 2022 December 1, 2025
NCT05104229 Withdrawn Phase 3 SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery June 1, 2024 January 1, 2026
NCT04795960 Withdrawn N/A Microbiome Modification to Enhance Stelara Response in Crohn's Disease March 18, 2021 March 2023
NCT00179842 Withdrawn Phase 2 Immune Ablation and Stem Cell Support for Crohn's Disease December 2008
NCT05471492 Withdrawn Phase 2 Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease July 30, 2023 August 15, 2026
NCT04944797 Withdrawn Crohn and Anal Incontinence March 30, 2022 March 30, 2022
NCT02974322 Withdrawn Phase 3 A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease December 1, 2017 December 24, 2018
NCT04982666 Withdrawn N/A Whole-Food, Plant-Based Diet for Active Crohn's Disease April 2022 October 2022
NCT04655807 Withdrawn Phase 2 A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease March 3, 2021 September 4, 2023
NCT05246943 Withdrawn The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients May 25, 2022 November 4, 2022
MeSH unique ID (MeSH (Medical Subject Headings))
D003424